X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
oncology (12) 12
humans (8) 8
tumors (7) 7
female (6) 6
mutation (6) 6
adult (5) 5
cancer (5) 5
male (5) 5
middle aged (5) 5
mutations (5) 5
aged (4) 4
article (4) 4
circulating tumor dna (4) 4
deoxyribonucleic acid--dna (4) 4
evolution (4) 4
genetic aspects (4) 4
hematology (4) 4
patients (4) 4
therapy (4) 4
adults (3) 3
aged, 80 and over (3) 3
carcinoma (3) 3
children (3) 3
development and progression (3) 3
expression (3) 3
gene expression profiling (3) 3
genes (3) 3
genomics (3) 3
infant (3) 3
pediatrics (3) 3
resistance (3) 3
respiratory system (3) 3
young adult (3) 3
abridged index medicus (2) 2
acquired-resistance (2) 2
adenocarcinoma (2) 2
adolescent (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic agents - therapeutic use (2) 2
biopsy (2) 2
cell lung-cancer (2) 2
child, preschool (2) 2
clonal hematopoiesis (2) 2
diagnosis (2) 2
dna fingerprinting (2) 2
dna sequencing (2) 2
drug resistance, neoplasm - genetics (2) 2
fibrosarcoma (2) 2
gene expression regulation, neoplastic (2) 2
gene mutations (2) 2
gene sequencing (2) 2
health aspects (2) 2
heterogeneity (2) 2
kinases (2) 2
leukemia (2) 2
liquid biopsy (2) 2
lung neoplasms - drug therapy (2) 2
lung-cancer (2) 2
medical research (2) 2
medicine, experimental (2) 2
medicine, research & experimental (2) 2
melanoma (2) 2
molecular targeted therapy (2) 2
next-generation sequencing (2) 2
nsclc (2) 2
profiling (2) 2
receptor, trka - genetics (2) 2
research (2) 2
solid tumors (2) 2
treatment outcome (2) 2
1st (1) 1
301.152tele (1) 1
321.1/.8 (1) 1
342.7 (1) 1
acneiform eruptions - chemically induced (1) 1
acneiform eruptions - pathology (1) 1
acute lymphatic leukemia (1) 1
acute lymphoblastic-leukemia (1) 1
acute myeloid leukemia (1) 1
acute myeloid-leukemia (1) 1
advanced solid tumors (1) 1
alectinib (1) 1
alk (1) 1
alk fusion (1) 1
alk g1202r solvent front mutation (1) 1
alk plus nsclc (1) 1
alk+ nsclc (1) 1
alterations (1) 1
aml (1) 1
amplification (1) 1
analysis (1) 1
anaplastic ganglioglioma (1) 1
angiogenesis (1) 1
animal structures (1) 1
annotations (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 06/2016, Volume 126, Issue 6, pp. 2334 - 2340
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2017, Volume 176, Issue 1, pp. 86 - 91
Journal Article
Journal Article
Journal Article
The oncologist, ISSN 1083-7159, 07/2019, p. theoncologist.2019-0214
loss-of-function (LOF) genomic alterations are associated with focal tandem duplications (FTDs) in ovarian and prostate cancers. Because these FTDs may produce... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2773 - 2773
Abstract Introduction: The BeatAML master trial is evaluating the use of precision medicine via genomically guided therapy in acute myeloid leukemia (AML). A... 
Journal Article
Lung Cancer, ISSN 0169-5002, 2017, Volume 106, pp. 110 - 114
Highlights • SCLC transformation is a resistance mechanism to ALK inhibitors. • Liquid biopsy missed morphologic examination. • Emergence of Rb1 C706Y and p53... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | Small cell lung cancer transformation | ALK G1202R solvent front mutation | Lorlatinib | Rb1 C706Y | Circulating tumor DNA | ALK+ NSCLC | ADENOCARCINOMA | EML4-ALK FUSION | ACQUIRED-RESISTANCE | 1ST | ALK plus NSCLC | ONCOLOGY | RESPIRATORY SYSTEM | ALECTINIB | Rbl C706Y | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - metabolism | Middle Aged | Lung Neoplasms - pathology | Male | Small Cell Lung Carcinoma - drug therapy | Small Cell Lung Carcinoma - metabolism | Cell Transformation, Neoplastic - genetics | Fatal Outcome | Adult | Female | Lactams, Macrocyclic - administration & dosage | Lactams, Macrocyclic - therapeutic use | Retinoblastoma Binding Proteins - genetics | Carcinoma, Non-Small-Cell Lung - pathology | Pyridines | Neoplastic Cells, Circulating - drug effects | Liquid Biopsy - methods | Pyrazoles | Carcinoma, Non-Small-Cell Lung - metabolism | Disease Progression | Drug Resistance, Neoplasm - genetics | Small Cell Lung Carcinoma - pathology | Receptor Protein-Tyrosine Kinases - genetics | Protein Kinase Inhibitors - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Ubiquitin-Protein Ligases - genetics | Tumor proteins | Medical colleges | Genetic aspects | Development and progression | Lung cancer, Small cell | Lung cancer, Non-small cell
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 11/2018, Volume 9, Issue 88, pp. 35809 - 35812
CGP results from >60,000 cases were screened to identify NTRK fusion events from cases of neuroendocrine tumors. 2417 NET patients from diverse anatomic sites... 
Next-generation sequencing | NTRK | NET | Neuroendocrine tumor | Neuroendocrine cancer
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2541 - 2541
Introduction: Histiocytic and dendritic neoplasms are a diverse group of uncommon hematologic tumors arising from monocytic or dendritic cell lineage. While... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 4_suppl, pp. 569 - 569
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2145 - 2145
Background: NGS of myeloid mutations is an integral part of AML clinical decision-making. There is currently no information regarding concordance between NGS... 
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 10/2019, Volume 155, Issue 1, pp. 144 - 150
Cervical cancer (CC) remains a major health problem worldwide. Poly (adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitors (PARPi) have emerged as a... 
PAR | Olaparib | PARP | Cervical cancer | CELLS | OVARIAN-CANCER | COMBINATION | TUMORS | MAINTENANCE THERAPY | OBSTETRICS & GYNECOLOGY | REPAIR | ONCOLOGY | AZD2281 | INHIBITORS
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.